Study Stopped
Difficulties with recruitment
Corneal Neurotization as a Treatment for Neurotrophic Keratopathy
Corneal Neurotization Via Sural Nerve Transfer or Cadaveric Nerve Graft for Neurotrophic Keratopathy
1 other identifier
interventional
4
1 country
1
Brief Summary
The purpose of this study is to assess the efficacy of sural nerve transfer and cadaveric nerve graft to re-establish corneal sensation in patients with neurotrophic keratopathy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 15, 2018
CompletedFirst Submitted
Initial submission to the registry
May 14, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 12, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 12, 2020
CompletedFirst Posted
Study publicly available on registry
April 12, 2023
CompletedApril 12, 2023
March 1, 2023
1.9 years
May 14, 2018
March 29, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Corneal sensation
Corneal sensation will be measured via Cochet Bonnet esthesiometry
Baseline (pre-operative) to 12 months postoperatively
Secondary Outcomes (2)
Visual acuity
Baseline (pre-operative) to 12 months postoperatively
Corneal opacity
Baseline (pre-operative) to 12 months postoperatively
Study Arms (1)
Corneal neurotization
EXPERIMENTALPatients will undergo the corneal neurotization as described in the protocol. Their pre and post-procedure corneal sensation will be measured as a primary outcome measure. Secondary outcome measures will include visual acuity, corneal opacity, NEI VFQ, and confocal microscopy.
Interventions
Autologous sural nerve will be harvested or cadaveric nerve graft will be coapted to an intact sensory branch of the trigeminal nerve. The nerve will be separated into fascicles which will be tunneled under the conjunctiva around the cornea near the limbus.
Eligibility Criteria
You may qualify if:
- Patients with neurotrophic cornea
You may not qualify if:
- Patients with history of penetrating keratoplasty
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Andrea Kossler
Palo Alto, California, 94303, United States
Related Publications (6)
Ramaesh K, Stokes J, Henry E, Dutton GN, Dhillon B. Congenital corneal anesthesia. Surv Ophthalmol. 2007 Jan-Feb;52(1):50-60. doi: 10.1016/j.survophthal.2006.10.004.
PMID: 17212990BACKGROUNDBonini S, Rama P, Olzi D, Lambiase A. Neurotrophic keratitis. Eye (Lond). 2003 Nov;17(8):989-95. doi: 10.1038/sj.eye.6700616.
PMID: 14631406BACKGROUNDMantelli F, Nardella C, Tiberi E, Sacchetti M, Bruscolini A, Lambiase A. Congenital Corneal Anesthesia and Neurotrophic Keratitis: Diagnosis and Management. Biomed Res Int. 2015;2015:805876. doi: 10.1155/2015/805876. Epub 2015 Sep 16.
PMID: 26451380BACKGROUNDElbaz U, Bains R, Zuker RM, Borschel GH, Ali A. Restoration of corneal sensation with regional nerve transfers and nerve grafts: a new approach to a difficult problem. JAMA Ophthalmol. 2014 Nov;132(11):1289-95. doi: 10.1001/jamaophthalmol.2014.2316.
PMID: 25010775BACKGROUNDTerzis JK, Dryer MM, Bodner BI. Corneal neurotization: a novel solution to neurotrophic keratopathy. Plast Reconstr Surg. 2009 Jan;123(1):112-120. doi: 10.1097/PRS.0b013e3181904d3a.
PMID: 19116544BACKGROUNDSepehripour S, Lloyd MS, Nishikawa H, Richard B, Parulekar M. Surrogate Outcome Measures for Corneal Neurotization in Infants and Children. J Craniofac Surg. 2017 Jul;28(5):1167-1170. doi: 10.1097/SCS.0000000000003677.
PMID: 28570404BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Oculoplastic Surgery & Orbital Oncology Assistant Professor of Ophthalmology
Study Record Dates
First Submitted
May 14, 2018
First Posted
April 12, 2023
Study Start
March 15, 2018
Primary Completion
February 12, 2020
Study Completion
February 12, 2020
Last Updated
April 12, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share